Diabetic Eye Disease

Latest News

Image Credit: © Seventyfour - stock.adobe.com

Alimera completes recruitment for its NEW DAY study

By David Hutton, Managing Editor, Ophthalmology Times

May 25th 2023

According to the company, the study has now reached its goal of 300 patients enrolled to evaluate ILUVIEN as a first line, baseline therapy for DME.

This week in optometry: March 20-March 24

By Kassi Jackson, Editor

March 25th 2023

Do diabetes, diabetic retinal disease contribute to macular degeneration?

By A. Paul Chous, MA, OD, FAAO

March 21st 2023

Regeneron receives FDA acceptance, priority review of BLA for aflibercept 8 mg for wet AMD and DME

By Lynda Charters

February 23rd 2023

Surprising findings from the DRCR Retina Network Protocol AA

By A. Paul Chous, MA, OD, FAAO

January 23rd 2023

Video Series

Video Interviews

Podcasts

Dr. Kerry Gelb speaks with Dr. Jay M. Hainie in the second part of their discussion on diabetes of the eye!

Open Your Eyes with Dr Kerry Gelb featuring Dr. Jay Haynie in "diabetes of the eye"

Latest CME Events & Activities

(CME/CNE Credit) Analyzing Novel Tear Stimulating Treatments for Special Populations in Dry Eye Disease

(COPE Credit) Community Practice Connections™: Restoring the Surface – Impact of Preservatives and Novel Formulations in First Line Treatments for Dry Eye Disease

(CME/CNE Credit) Community Practice Connections™: Restoring the Surface Impact of Preservatives and Novel Formulations in First Line Treatments for Dry Eye Disease

C.R.U. Eye Symposium (Current, Relevant, Useful)

11/10/2023-11/12/2023

C.R.U. Eye Symposium (Current, Relevant, Useful)

11/10/2023-11/12/2023

Cases and Conversations™: New Treatment Strategies for nAMD & DME

07/28/2023

Cases and Conversations™: New Treatment Strategies for nAMD & DME

07/28/2023

Shared Perspectives in Managing Presbyopia – Understanding a New Paradigm for Optimizing Quality of Life

(CME Credit) Patient, Provider, and Caregiver Connection™: Individualizing Care in Allergic Conjunctivitis – Understanding the Patient’s Perspective in Alleviating Disease Burden

(COPE Credit) Analyzing Novel Tear Stimulating Treatments for Special Populations in Dry Eye Disease

(CME/CNE Credit) Analyzing Novel Tear Stimulating Treatments for Special Populations in Dry Eye Disease

(COPE Credit) Community Practice Connections™: Restoring the Surface – Impact of Preservatives and Novel Formulations in First Line Treatments for Dry Eye Disease

(CME/CNE Credit) Community Practice Connections™: Restoring the Surface Impact of Preservatives and Novel Formulations in First Line Treatments for Dry Eye Disease

The Optometry Times EyeCon 2023

Perfecting Co-Management of Glaucoma – Utilizing Development in the Spectrum of Treatment Options

Expert Insights in Geographic Atrophy with Transformative Care on the Horizon – Understanding the Complement System as a Target for Treatment

(COPE Credit) Patient, Provider, and Caregiver Connection™: Individualizing Care in Allergic Conjunctivitis – Understanding the Patient’s Perspective in Alleviating Disease Burden

(COPE Credit) Expert Illustrations & Commentaries™: Envisioning New Therapies for Meibomian Gland Dysfunction-Associated DED

More News

Managing low vision in an aging population

Parres Wright, OD, FAAO

January 5th 2023

As Baby Boomers enter the at-risk age group for vision loss, optometrists must be ready to act.

Have a patient with diabetes? Get the whole story

A. Paul Chous, MA, OD, FAAO

November 24th 2022

Case history can give clues to a patient’s risk of developing diabetic eye disease.

FDA approves intravenous injection for delayed onset of stage 3 type 1 diabetes

Lynda Charters

November 18th 2022

Teplizumab may work by binding to certain immune system cells that attack insulin-producing cells and increase the proportion of cells that help moderate the immune response, thus delaying progression to stage 3 type 1 diabetes.

It’s not your grandparents’ anti-VEGF therapy

A. Paul Chous, MA, OD, FAAO

August 22nd 2022

New DME treatments aim to extend time between intravitreal injections.

NIH-funded clinical trial results support “step therapy” for DME treatment

Kassi Jackson, Editor

August 19th 2022

A recent clinical trial from the DRCR Retina Network examined a stepped regimen of anti-VEGF drugs bevacizumab and aflibercept.

PDR: public health considerations

Autumnn Wooten, OD;Angelina Tran, OD;Bhagya Segu, OD, MPH, FAAO

August 9th 2022

Proper screenings, treatment, management needed for this increasingly prevalent disease.

Case study: Patient presents with severe PDR history

Autumnn Wooten, OD;Angelina Tran, OD;Bhagya Segu, OD, MPH, FAAO

August 8th 2022

The patient’s ocular history was significant for severe nonproliferative diabetic retinopathy (NPDR) in the right eye (OD) and mild NPDR in the left eye (OS), which had been diagnosed 4 years previously at his last eye exam.

2022 updates to ADA standards of care for patients with diabetes

A. Paul Chous, MA, OD, FAAO

May 30th 2022

The ADA now recommends an individualized approach at diagnosis of diabetes as well as for adults who do not have symptoms to be screened at age 35 years.

5 diabetes truisms that are (at least partially) false

A. Paul Chous, MA, OD, FAAO

March 25th 2022

Addressing common misconceptions can help avoid misconstrued scientific facts

Mitigate diabetic retinopathy with early improved glucose control

A. Paul Chous, MA, OD, FAAO

January 25th 2022

Timing is key in reducing the risk of developing vision loss or blindness.

RGX-314 clinical program: second pivotal trial to begin

Optometry Times Staff Reports

January 13th 2022

ASCENT, RegenXBio’s Phase III clinical trial conducted in partnership with AbbVie, is expected to enroll patients in the United States and Canada, with pivotal trials expected to support BLA submission for RGX-314 in 2024.

'Open Your Eyes' heads to premiere on Jan. 28

'Open Your Eyes' documentary to premiere this month

Optometry Times Staff Reports;Kerry Gelb, OD

January 2nd 2022

Exciting news from OYE Technology!

Optic disk swelling in an asymptomatic patient with diabetes

A. Paul Chous, MA, OD, FAAO

November 12th 2021

Diabetic papillitis is relatively rare, found in type 1 and 2 diabetes patients

COVID-19 triggers macrophage-mediated cytokine storm in diabetic patients

Lynda Charters

October 27th 2021

Central serous retinopathy is not a benign disease

Leo P. Semes, OD, FAAO

October 4th 2021

Remain vigilant to recurrences to apply potential treatments

ODs are ignoring macular degeneration

Steven Ferrucci, OD, FAAO

September 15th 2021

Practitioners spend more time diagnosing glaucoma or diabetic retinopathy than AMD

Impact of sleep on diabetes and diabetic retinopathy

A. Paul Chous, MA, OD, FAAO

August 19th 2021

Prescribed sleep hygiene may reduce the risk of severe eye disease and vision loss

How diabetes and glaucoma intersect

David Yang, OD, FAAO;Lee Vien, OD, FAAO

August 11th 2021

Consider the impact of diabetes on management of patients with glaucoma

Embrace, don’t fear, AI in diabetic retinopathy

A. Paul Chous, MA, OD, FAAO

May 11th 2021

Automated detection of disease helps patients as well as doctors

How ODs can address patients lost to follow up

A. Paul Chous, MA, OD, FAAO

January 4th 2021

Practitioners need to educate and stress the importance of additional care

How diabetes affects COVID-19

A. Paul Chous, MA, OD, FAAO

November 12th 2020

Considerations for eyecare providers to better care for their patients with diabetes

Medical optometry and comprehensive eye care

Scott Schachter, OD

October 19th 2020

Eye physicals should be full-scope

Pipeline: Potential new therapy coming for macular disease

Steven Ferrucci, OD, FAAO

October 9th 2020

Faricimab shows promise in treating diabetic macular edema and age-related macular degeneration

Patient education vs patient relations?

Mohammad Rafieetary, OD, FAAO

September 9th 2020

• Relatable patient education improves quality of care and prognosis • Although patients with moderate NPDR without DME can be followed every 6 to 9 months, when macular involvement is present patient needs more frequent follow-up • Patients with diabetic retinopathy need to be informed about importance of follow-up care even in the absence of their vision changes

Improve your detection rate of retinal neovascularization

Mohammad Rafieetary, OD, FAAO

September 9th 2020

If a complete examination is not possible in diabetic patients, pay close attention to the inferior retina.

12 lifestyle factors determine 40 percent of dementia cases

Brooke Henson, Editor

August 19th 2020

Aflibercept PANORAMA study results in

A. Paul Chous, MA, OD, FAAO

August 13th 2020

Patients who switched to as-needed dosing experienced increased complications

Diabetic retinopathy treatment practical review

Mohammad Rafieetary, OD, FAAO

August 5th 2020

When should ODs sends their patient to a retina specialist?

What causes vision loss in diabetic patients

Mohammad Rafieetary, OD, FAAO

August 5th 2020

Vision loss caused by diabetic retinopathy comes in different packages.

Role of comorbidities in management of diabetic retinopathy

Mohammad Rafieetary, OD, FAAO

July 7th 2020

ODs must pay close attention and manage all factors responsible for disease progression to improve the patient’s final outcome. The patient in this case report shows the importance of such management.

1 2 3 4 5 >

Do not sell my Information

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777